Management

Mr. Jhaveri served as Chief Financial Officer of Insilico Medicine, a clinical-stage, AI-based biotech, where he oversaw finance, corporate strategy and investor relations, with the company raising $110 million and securing over $100 million from business development transactions during his tenure. Previously, Mr. Jhaveri served as Chief Financial Officer of Journey Medical Corporation, a commercial-stage biopharmaceutical company, where he led business development, corporate strategy and capital raising. Earlier in his career, he held roles in business development at Fortress Biotech, equity research at Citigroup and investment banking at Bank of America. He earned his B.A. in Chemistry and Economics from the University of Pennsylvania and his MBA from New York University’s Stern School of Business. Mr. Jhaveri is a CFA charterholder.